Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $7,928 - $8,641
-73 Reduced 1.65%
4,344 $501,000
Q1 2023

May 09, 2023

BUY
$102.94 - $114.86 $23,882 - $26,647
232 Added 5.54%
4,417 $469,000
Q4 2022

Feb 02, 2023

SELL
$87.44 - $112.11 $77,296 - $99,105
-884 Reduced 17.44%
4,185 $464,000
Q3 2022

Nov 01, 2022

SELL
$84.53 - $94.96 $27,641 - $31,051
-327 Reduced 6.06%
5,069 $437,000
Q2 2022

Aug 04, 2022

BUY
$83.49 - $94.64 $54,435 - $61,705
652 Added 13.74%
5,396 $492,000
Q1 2022

May 05, 2022

BUY
$73.51 - $82.4 $4,851 - $5,438
66 Added 1.41%
4,744 $389,000
Q4 2021

Feb 07, 2022

BUY
$72.28 - $90.54 $11,564 - $14,486
160 Added 3.54%
4,678 $359,000
Q3 2021

Nov 01, 2021

SELL
$71.68 - $78.83 $1,361 - $1,497
-19 Reduced 0.42%
4,518 $339,000
Q2 2021

Aug 03, 2021

SELL
$70.31 - $77.77 $1,757 - $1,944
-25 Reduced 0.55%
4,537 $353,000
Q1 2021

Apr 19, 2021

BUY
$68.86 - $81.11 $3,167 - $3,731
46 Added 1.02%
4,562 $373,000
Q4 2020

Feb 01, 2021

BUY
$71.77 - $79.65 $20,813 - $23,098
290 Added 6.86%
4,516 $369,000
Q3 2020

Oct 22, 2020

BUY
$73.18 - $82.95 $16,319 - $18,497
223 Added 5.57%
4,226 $351,000
Q2 2020

Jul 30, 2020

SELL
$70.42 - $80.13 $22,463 - $25,561
-319 Reduced 7.38%
4,003 $310,000
Q1 2020

Apr 30, 2020

SELL
$63.36 - $87.82 $55,756 - $77,281
-880 Reduced 16.92%
4,322 $333,000
Q4 2019

Feb 11, 2020

SELL
$77.58 - $87.54 $91,466 - $103,209
-1,179 Reduced 18.48%
5,202 $473,000
Q3 2019

Oct 31, 2019

BUY
$76.08 - $82.93 $7,912 - $8,624
104 Added 1.66%
6,381 $537,000
Q2 2019

Aug 02, 2019

BUY
$69.84 - $81.59 $16,482 - $19,255
236 Added 3.91%
6,277 $526,000
Q1 2019

May 03, 2019

BUY
$69.58 - $79.36 $228,639 - $260,776
3,286 Added 119.27%
6,041 $502,000
Q4 2018

Feb 04, 2019

BUY
$65.24 - $75.71 $179,736 - $208,581
2,755 New
2,755 $211,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $223B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bhk Investment Advisors, LLC Portfolio

Follow Bhk Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bhk Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bhk Investment Advisors, LLC with notifications on news.